GRIN2B, glutamate ionotropic receptor NMDA type subunit 2B, 2904
N. diseases: 249; N. variants: 83
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 12 | 13611773 | inframe deletion | AAGACA/- | delins |
|
0.700 | 0 | |||||||||||||
|
12 | 13981909 | splice region variant | C/A | snv | 0.37 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 12 | 13567265 | splice acceptor variant | T/C | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 12 | 13570019 | splice acceptor variant | T/C | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 12 | 13753523 | frameshift variant | GT/- | delins |
|
0.700 | 0 | |||||||||||||
|
0.925 | 12 | 13567063 | frameshift variant | A/- | del |
|
0.700 | 0 | |||||||||||||
|
0.925 | 12 | 13567063 | frameshift variant | A/- | del |
|
0.700 | 0 | |||||||||||||
|
1.000 | 12 | 13866109 | frameshift variant | -/G | delins |
|
0.700 | 0 | |||||||||||||
|
1.000 | 0.040 | 12 | 13562374 | 3 prime UTR variant | A/C;G | snv |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2015 | 2016 | ||||||||
|
0.851 | 0.160 | 12 | 13561429 | 3 prime UTR variant | G/T | snv | 0.33 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.851 | 0.160 | 12 | 13561429 | 3 prime UTR variant | G/T | snv | 0.33 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.160 | 12 | 13561429 | 3 prime UTR variant | G/T | snv | 0.33 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.160 | 12 | 13561429 | 3 prime UTR variant | G/T | snv | 0.33 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.882 | 0.080 | 12 | 13561795 | 3 prime UTR variant | T/A;C;G | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.882 | 0.080 | 12 | 13561795 | 3 prime UTR variant | T/A;C;G | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.882 | 0.080 | 12 | 13561795 | 3 prime UTR variant | T/A;C;G | snv |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.040 | 12 | 13561125 | 3 prime UTR variant | A/G | snv | 8.5E-03 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.040 | 12 | 13561125 | 3 prime UTR variant | A/G | snv | 8.5E-03 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.790 | 0.200 | 12 | 13561247 | 3 prime UTR variant | A/G | snv | 0.25 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.790 | 0.200 | 12 | 13561247 | 3 prime UTR variant | A/G | snv | 0.25 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.790 | 0.200 | 12 | 13561247 | 3 prime UTR variant | A/G | snv | 0.25 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.790 | 0.200 | 12 | 13561247 | 3 prime UTR variant | A/G | snv | 0.25 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.790 | 0.200 | 12 | 13561247 | 3 prime UTR variant | A/G | snv | 0.25 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.790 | 0.200 | 12 | 13561247 | 3 prime UTR variant | A/G | snv | 0.25 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.790 | 0.200 | 12 | 13561247 | 3 prime UTR variant | A/G | snv | 0.25 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 |